News

Published: 12 May 2022

DCAT Week 2022 Interview: Enrico Giaquinto, Chief Industrial Operations Officer of Angelini Pharma

Highlights of the discussion with Enrico Giaquinto | Angelini Pharma

Published: 19 Apr 2022

“CRDMO” the new business model for future of the (Bio)Pharma Industry

Today CDMOs face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm...

Published: 21 Feb 2022

Angelini Pharma continues its commitment to HPAPI services

Facing the rising number of custom HPAPIs demand, Angelini Fine Chemicals decided to expand its HPAPI capacity at its Aprilia,Italy plant site

Published: 21 Oct 2021

Flow Chemistry as novel chirotechnologic tool for asymmetric synthesis of APIs

The continuous-flow enantioselective processes have to be seen as a pivot point for sustainable development of the tomorrow’s pharmaceutical industry

Published: 5 Oct 2021

Modern and future strategic trends of the pharma outsourcing market

Today Contract Development Manufacturing Organizations (CDMOs) face excellent growth opportunities in a pharmaceutical market environment where using outsourcing services is becoming the new norm

Published: 8 Jul 2021

Flow chemistry for efficient and safe synthesis of APIs

Today, a confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market

Published: 6 Jul 2021

Angelini Fine Chemicals is expanding its catalytical hydrogenation capacity with two reactors

Angelini Fine Chemicals, Business Unit of Angelini Pharma, specialized in the production of active pharmaceutical ingredients, has installed two reactors for catalytic hydrogenation in the Aprilia (LT) plant...